The Brooklyn native saw a doctor and the news wasn’t good — he was diagnosed with Guillain-Barré syndrome ... a very rare variant of Guillain-Barré that typically means a faster onset ...
COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will present new data on minimal residual disease (MRD) negativity rates from the Phase 3 CARTITUDE-4 trial ...
Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...
This marks the third year that vaccine manufacturers have updated their COVID-19 vaccine formulations to better match circulating variants ... condition Guillain-Barré syndrome in people 65 ...